Claro Advisors LLC Novo Nordisk A S Transaction History

Claro Advisors LLC

$706 Million
Q3 2024

A detailed history of Claro Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Claro Advisors LLC holds 26,088 shares of NVO stock, worth $2.65 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

26,088

Previous 2,467 957.48%

Holding current value

$2.65 Million

Previous $293,000 960.07%

% of portfolio

0.44%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$119.07 - $145.42 $2.81 Million - $3.43 Million	23,621 Added 957.48%	26,088 $3.11 Million
Q3 2024 Oct 17, 2024	SELL	$119.07 - $145.42 $2.51 Million - $3.07 Million	-21,112 Reduced 89.54%	2,467 $293,000
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $41,844 - $50,096	341 Added 1.47%	23,579 $3.37 Million
Q1 2024 Apr 18, 2024	BUY	$102.11 - $135.92 $75,867 - $100,988	743 Added 3.3%	23,238 $2.98 Million
Q4 2023 Jan 22, 2024	BUY	$87.78 - $105.45 $1,492 - $1,792	17 Added 0.08%	22,495 $2.33 Million
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $1.01 Million - $2.21 Million	11,082 Added 97.24%	22,478 $2.04 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $14,038 - $15,538	90 Added 0.8%	11,396 $1.84 Million
Q1 2023 Apr 17, 2023	SELL	$132.34 - $159.14 $2,514 - $3,023	-19 Reduced 0.17%	11,306 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $39,994 - $52,778	390 Added 3.57%	11,325 $1.53 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $51,413 - $60,661	498 Added 4.77%	10,935 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $23,490 - $28,684	245 Added 2.4%	10,437 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $101,979 - $128,796	1,208 Added 13.45%	10,192 $979,000
Q2 2021 Aug 13, 2021	BUY	$67.66 - $84.76 $5,277 - $6,611	78 Added 0.88%	8,984 $753,000
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $93,615 - $105,844	-1,396 Reduced 13.55%	8,906 $600,000
Q4 2020 Feb 12, 2021	BUY	$63.89 - $73.8 $4,727 - $5,461	74 Added 0.72%	10,302 $720,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $7,833 - $8,637	-123 Reduced 1.19%	10,228 $710,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $10,537 - $12,229	180 Added 1.77%	10,351 $678,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $14,442 - $18,915	292 Added 2.96%	10,171 $612,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $52,602 - $61,464	1,055 Added 11.96%	9,879 $572,000
Q3 2019 Oct 29, 2019	BUY	$47.54 - $53.43 $1,140 - $1,282	24 Added 0.27%	8,824 $456,000
Q2 2019 Jul 24, 2019	BUY	$46.79 - $52.47 $7,392 - $8,290	158 Added 1.83%	8,800 $449,000
Q1 2019 May 10, 2019	SELL	$46.36 - $52.63 $6,675 - $7,578	-144 Reduced 1.64%	8,642 $452,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $364,970 - $415,138	8,786 New	8,786 $414,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claro Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claro Advisors LLC with notifications on news.

Account

Claro Advisors LLC Novo Nordisk A S Transaction History